Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Bronsted Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115572310A reveals a solvent-free Bronsted acid catalyzed method for synthesizing alpha,alpha-disubstituted-gamma-ketophosphine oxides with high atom economy.
Patent CN120965623A reveals a green organic catalytic route for 2-functionalized-2,5-dihydrofurans. Achieve high purity and cost reduction in fine chemical manufacturing with scalable methods.
Patent CN100567236C details a green synthesis for Antioxidant 330 using ionic liquids, offering high purity and simplified workup for polymer additive supply chains.
Novel BRD4 inhibitors synthesis via patent CN109020976A. High yield, mild conditions, scalable pharmaceutical intermediates manufacturing for global supply chains.
Patent CN116283922A reveals a Bronsted acid-catalyzed method for EGFR inhibitor intermediates, offering higher yields and metal-free processing for reliable supply chains.
Patent CN103408502A details a Bronsted acid-catalyzed, metal-free route to quinazolinones using O2. This method ensures high purity and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel CSA-catalyzed route offers high yield and room temperature operation for cost-effective pharmaceutical intermediate manufacturing and scalable production.
Novel Bronsted acid-catalyzed route for spiro-oxindoles using 2,5-dimethylfuran. High yield, metal-free, scalable pharmaceutical intermediate manufacturing.
Patent CN111138299A details a solvent-free method for triarylmethanes. Offers high purity, reduced waste, and scalable production for pharma intermediates.
Patent CN111808106A discloses a novel acid-catalyzed route for pyrrolo[1,2-a]indoles. This method offers high yields, mild conditions, and significant cost reduction potential for supply chains.
Patent CN103880755A reveals a green catalytic route for 2,4,5-triaryl imidazoles using a biodegradable Brönsted acid, offering cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Patent CN121378226A reveals a mild synthesis method for oxindole compounds with high yield. This offers cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN116063223A reveals a metal-free TfOH catalyzed route for 10-perfluoroalkyl-5,10-dihydroindeno[1,2-b]indoles, offering high yields and scalable manufacturing for pharmaceutical intermediates.
Discover a novel antitumor compound synthesis with 92-99% yield, mild conditions, and strong HONE-1 cytotoxicity. Optimize your drug development supply chain.